Table-IV.
Comparative analysis of T lymphocyte subsets between the two groups before and after treatment (χ̅±S)n=40.
| Indexes | Study group | Control group | t | p | |
|---|---|---|---|---|---|
| CD3+ (%) | Before treatment | 42.66±6.45 | 42.86±6.19 | 0.149 | 0.882 |
| After treatment* | 48.57±6.37 | 43.29±6.14 | 3.776 | 0.000 | |
| CD4+ (%) | Before treatment | 27.31±4.12 | 27.52±3.83 | 0.236 | 0.814 |
| After treatment* | 38.26±4.66 | 34.07±4.84 | 3.944 | 0.000 | |
| CD8+ (%) | Before treatment | 21.46±3.71 | 21.72±3.72 | 0.313 | 0.755 |
| After treatment* | 22.05±3.73 | 22.18±3.88 | 0.153 | 0.879 | |
| CD4+/CD8+ | Before treatment | 1.28±0.10 | 1.28±0.07 | 0.225 | 0.823 |
| After treatment* | 1.76±0.18 | 1.55±0.16 | 5.255 | 0.000 |
p <0.05.